Oncology
Hello, Mary O'connor
Manage E-mail  |  Logout

Article ID

Home
General Oncology
Messages (0)
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain Management/
    Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Top Ten Searches
brca1  brca1
prostate-specific antigen  prostate-specific antigen
sclc  sclc
fobt  fobt
egd  egd
bmi  bmi
dysplasia  dysplasia
hematologic  hematologic
ovarian  ovarian
hcc  hcc
 
Sponsor

Articles: Endocrine Oncology



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas
Histopathology, 09/04/09
Sponsor
Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
Journal of Clinical Endocrinology and Metabolism, 09/03/09
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma
Journal of Clinical Oncology, 09/02/09
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death
International Journal of Radiation Oncology*Biology*Physics, 09/01/09
Stereotactic Body Radiotherapy for Treatment of Adrenal Metastases
International Journal of Radiation Oncology*Biology*Physics, 08/31/09
An epitome of DNA repair related genes and mechanisms in thyroid carcinoma
Cancer Letters, 08/31/09
Use of hormone replacement therapy and the risk of colorectal cancer
Journal of Clinical Oncology, 08/28/09
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
New England Journal of Medicine, 08/26/09
Effect of exercise on postmenopausal sex hormone levels and role of body fat: A randomized controlled trial
Journal of Clinical Oncology, 08/25/09
Postoperative radiation therapy after complete resection of thymoma has little impact on survival
Cancer, 08/20/09
Medullary thyroid carcinoma with poor differentiation and atypical radiographic pattern of metastasis
Pathology International, 08/19/09
Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor
Journal of Clinical Oncology, 08/17/09
Management of Endocrine Manifestations and the Use of Mitotane as a Chemotherapeutic Agent for Adrenocortical Carcinoma
Journal of Clinical Oncology, 08/17/09
Identification of borderline thyroid tumors by gene expression array analysis
Cancer, 08/13/09
Exclusive Author Commentary
Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors
Oncogene, 08/13/09
Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion
Medical Oncology, 08/13/09
Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer
Journal of Clinical Oncology, 08/10/09
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
Cancer Chemotherapy and Pharmacology, 08/05/09
Predictors of response to exemestane as primary endocrine therapy in estrogen receptor–positive breast cancer
Cancer Science, 08/04/09
Suppressor of Cytokine Signaling 3 Sensitizes Anaplastic Thyroid Cancer to Standard Chemotherapy
Cancer Research, 08/03/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.